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General Introduction 
Supply of high-quality pharmaceutical products is one of the most important tasks to 
guarantee the medication safety.  In the formulation design of pharmaceutical products, 
the adequate administration route and dosage form are chosen with consideration for 
physical, chemical, and biochemical properties of an active pharmaceutical ingredient.  
Additionally in most cases, the pharmaceutical products which have the suitable product 
performance are designed in order to maximize their drug efficacy or to improve patient 
compliance and convenience. 1-6  The pharmaceutical product performance such as 
dissolution, disintegration, moisture-absorbability, and stability has effects on the 
bioavailability and quality of the products.  Therefore, the pharmaceutical product 
performance should be appropriately controlled. 
Now, manufacturing and quality management of pharmaceutical products are 
controlled by the pharmaceutical regulations in individual countries.  The quality and 
important pharmaceutical product performance are evaluated in the quality inspection 
before shipping (Figure 1).  Then only lots which conform to the acceptance criteria 
are shipped.  The conventional strategy for the formulation design and quality 
management like this, however, is inefficient and sometimes unscientific.  Accordingly, 
the concept of Quality by design (QbD) has received a lot of attention to supply 
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high-quality pharmaceutical products stably and efficiently.  In ICH harmonised 
tripartite guideline Q8(R2), QbD is defined as ‘a systematic approach to development 
that begins with predefined objectives and emphasizes product and process 
understanding and process control, based on sound science and quality risk 
management’. 7  This concept is the new strategy for the formulation design and 
quality management (Figure 1).  Robust manufacturing processes should be developed 
based on the scientific evidence such as process understanding and scientific process 
control, which lead to constant supply of high-quality pharmaceutical products.  By 
proposal of the concept of QbD, the formulation design and quality management based 
on the scientific evidence becomes increasingly important.  To understand the 
mechanism of the pharmaceutical product performance is a valid approach.  In 
addition, it makes the formulation design more effective. 
In order to understand the mechanism of the pharmaceutical product performance, it 
is absolutely necessary to understand the physical properties of ingredients inside 
products accurately.  Because their physical properties, especially crystal structures 
influence their own solubility, moisture-absorbability, and stability, which eventually 
induce the change in pharmaceutical product performance. 8-15  In this thesis, we 
utilized near-infrared (NIR) spectroscopy as a tool to evaluate the physical properties of 
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ingredients inside products.  NIR spectroscopy has significant light penetration 
property and is a non-destructive and non-invasive technique.  By using NIR 
spectroscopy, it is possible to reveal the physical or chemical state of the component 
inside sample. 16, 17  Thus, NIR spectroscopy has been widely used for the quality 
evaluation of pharmaceutical products. 18-23  In addition, NIR spectrum is more 
sensitive to changes in hydrogen bonding, compared to infrared spectroscopy and 
Raman spectroscopy, making it possible to elucidate subtle but important 
molecular-level variations in the sample.  Consequently, NIR spectroscopy is a 
powerful tool for the evaluation of the physical properties, especially crystal structures 
of ingredients inside products. 
We used NIR imaging in some studies in this thesis.  As shown in Figure 2, NIR 
imaging measures a series of NIR spectra for every pixel which divides an object into 
several spatial parts.  Therefore, it can provide spatial and chemical information.  To 
reveal the distribution and the chemical or physical state of a certain ingredient in a 
product can lead to the in-depth understanding of variation in pharmaceutical product 
performance. 
Although NIR spectroscopy and NIR imaging provide a lot of information, they have 
a difficulty in their data analysis.  NIR spectra are complicate because of broadening 
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and overlapping of many overtone and combination bands.  The appropriate spectrum 
analysis is really important to extract essential information from complicated spectra.  
As a solution for this problem, chemometrics methods have often been applied.  It 
enables one to extract the essential information about the objects of interest in the data 
by using statistical or mathematical techniques. 
 
In this thesis, NIR spectroscopy was applied to the quality evaluation of 
pharmaceutical tablets.  We revealed effects of tablet manufacturing processes on the 
physical properties of ingredients.  Moreover, we investigated how the variations in the 
physical properties change pharmaceutical product performance. 
In Chapter 1, we investigated effect of the grinding process on dissolution profile 
using NIR imaging.  In many studies using NIR imaging, while interpretation of 
distribution image of a certain ingredient is focused on, the detailed analysis of NIR 
spectra is often overlooked.  In the study in Chapter 1, NIR imaging combined with 
self-modeling curve resolution (SMCR) analysis revealed that the grinding process 
changed the crystal structure of an active pharmaceutical ingredient.  In addition, the 
distribution of the ingredients inside tablets was quantified by SMCR analysis.  These 
results clarified effects of grinding process on dissolution property of tablets. 
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In Chapter 2, we investigated effects of grinding process on pharmaceutical product 
performance of tablets containing microcrystalline cellulose (MCC) at the molecular 
level.  MCC is a well-known excipient commonly included in pharmaceutical tablets 
as diluent, binder, and disintegrator.  It is well-known that the crystal structures of 
active pharmaceutical ingredients can influence on pharmaceutical product 
performance.10-12  Therefore, their crystal structures are strictly controlled during the 
manufacturing processes.  On the other hand, the crystal structures of excipients are 
often overlooked, even though their crystal structures can also affect pharmaceutical 
product performance. 13-15  In the study in Chapter 2, it was revealed that the grinding 
process changed the crystallinity of MCC.  We also discussed the mechanism that the 
variation in MCC crystallinity induced by grinding process changed the 
moisture-absorbability of the tablet. 
In Chapter 3, we used more practical tablets containing MCC and investigated the 
actual effects of MCC crystallinity on pharmaceutical product performance of the 
tablets.  In the study in Chapter 2 and other previous study 24, we reported that some 
manufacturing processes decreased the crystallinity of MCC, which eventually led to 
the change in compression moldability, dissolution profile, and moisture-absorbability 
of tablets.  It is also reported that the variation of the crystal structure of MCC affects 
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the hardness and dissolution profile of tablets. 15  However, the tablets used in these 
studies were constructed mainly from MCC, using 80 – 90% of MCC.  Actual effects 
of MCC crystallinity on actual pharmaceutical tablets containing a much smaller 
amount of MCC is not fully understood yet.  In the study in Chapter 3, it was revealed 
that the water-penetration and moisture-absorbability of the tablets were influenced by 
MCC crystallinity even when the tablets contained only 20% MCC.  In addition, the 
results also indicated that the change in moisture-absorbability had crucial effects on the 
stability of tablets which is one of the most important pharmaceutical product 
performance. 
In Chapter 4, we monitored the transient variations in the crystallinity of MCC inside 
tablets during storage using NIR spectroscopy.  Crystal structures of active 
pharmaceutical ingredients are strictly controlled during the manufacturing processes of 
pharmaceutical products as well as during storage.  On the other hand, the crystal 
transformation behavior of excipients during storage has hardly been investigated, even 
though their crystal structures can affect pharmaceutical product performance as 
described in Chapter 2 and Chapter 3.  In the study in Chapter 4, it was revealed that 
the crystal transformation behavior of MCC depended on the humidity condition during 
storage.  In Addition, it is also indicated that the incorporation of other excipient 
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influenced the crystal transformation behavior of MCC. 
 
In this thesis, we revealed that the manufacturing process of pharmaceutical products 
can change the physical properties of ingredients, which eventually changes the 
pharmaceutical product performance of tablets.  These results must be useful 
applications in controlling the quality of pharmaceutical products based on the scientific 
evidence. 
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Figure 1 Strategy of quality management 
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Figure 2 Schematic of NIR imaging 
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Chapter 1 
 
Self-modeling Curve Resolution (SMCR) 
Analysis of Near-infrared (NIR) Imaging Data 
of Pharmaceutical Tablets 
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Abstract 
The idea of Quality by design (QbD) has been proposed in pharmaceutical field.  
QbD is a systematic approach to control the product performance based on the scientific 
understanding of the product quality and its manufacturing process.  In this study, 
near-infrared (NIR) imaging was utilized as a tool to achieve this concept.  A practical 
use of a chemometrics technique called Self-modeling Curve Resolution (SMCR) was 
demonstrated with NIR imaging analysis of wax matrix tablets containing two 
ingredients, a soluble active ingredient, pentoxifylline (PTX), and an insoluble excipient, 
palmitic acid.  Concentration profiles obtained by SMCR revealed that the 
homogenous distribution of chemical ingredients strongly depended on the grinding 
time.  In addition, pure component spectra by SMCR indicated a sequential change of 
specific NIR peak intensities following the increase of the grinding time.  The spectra 
change showed the molecular structure change of PTX related to its crystallinity during 
grinding process.  These results indicate that the grinding process plays a central role 
in quantitative control, that is to say, sustain-release of PTX from the wax matrix tablet.  
This study, consequently, clearly demonstrates that NIR imaging combined with SMCR 
can be a powerful tool to reveal the mechanism of chemical or physical changes induced 
by the manufacturing process of pharmaceutical products, which can lead to a solid 
 21/139 
solution for QbD of pharmaceutical products. 
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1. Introduction 
To supply high-quality pharmaceutical products stably and efficiently, one of the 
important tasks is to control the quality of pharmaceutical products based on the 
scientific evidence.  As one of approaches to this task, the concept of Quality by 
design (QbD) has been proposed.1  The quality of pharmaceutical products should be 
controlled based on scientific understanding of their quality attributes, formulation, and 
manufacturing process. 
Recently, infrared (IR), near-infrared (NIR), Raman and terahertz pulsed imaging 
technology have been utilized as a tool to evaluate the quality of pharmaceutical 
products, such as the ingredient distribution, the polymorph ratio inside tablets, and 
coating thickness.2-7  These techniques based on vibration spectroscopy make it 
possible to reveal the mechanism of physical or chemical changes at the molecular level.  
The understanding of such mechanism can be a key factor for the quality control of 
pharmaceutical products.  That is, these spectroscopic imaging technologies can be a 
solid solution for QbD.  In this study NIR imaging was applied to understand 
mechanism in the grinding process which is one of the pharmaceutical tablet 
manufacturing processes. 
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NIR imaging measures a series of NIR spectra for every pixel which divides an 
object into several spatial parts.  A unique feature of NIR imaging technique is that it 
offers not only spatial distribution of objects but also structural information strongly 
related to hydrogen bonding which is one of the key factors for crystal structure.  In 
spite of these advantages, NIR imaging sometimes has a difficulty in its data analysis.  
Imaging data which has a high dimensional structure composed of two spatial and one 
spectral dimensions are generally difficult to be directly and intuitively interpreted.  As 
a solution for this problem, chemometrics methods have often been applied to take the 
full advantage of the spectral and spatial information contained in the imaging data.  It 
enables one to extract the essential information about the objects of interest in the data 
by using statistical or mathematical techniques. 
An example of these chemometrics techniques is principal component analysis 
(PCA).8-10  Another example of popular chemometrics technique is a family of 
multivariate curve resolution techniques called self-modeling curve resolution 
(SMCR).11-14  SMCR techniques have widely been studied since its first introduction 
by Lawton and Sylvester,15 and it has also been successively introduced to multivariate 
imaging analysis.11, 16  SMCR utilizes a certain mathematical data decomposition 
procedure to deconvolve instrumentally unresolved two-way signals generated from 
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multi-component mixtures into individual factors for single species.12, 13  The only 
premises which SMCR requires are bilinear data structure and some generic knowledge 
about the pure variables, such as non-negativity, unimodality, closure of the 
concentration, or spectral profiles.  Compared with PCA, SMCR provides information 
closely related to physical or chemical model of data.  Instead of scores and loadings 
mathematically constrained to be orthogonal, SMCR deconvolutes original data into 
concentration profiles matrix C and pure component spectra matrix S.  Concentration 
profiles and pure component spectra represent physical or chemical distribution of main 
contributing sources among samples and corresponding chemical compositions.  For 
example, in SMCR with multivariate imaging data, C can be seen as the spatial 
distribution of each chemical species and S corresponds to their true spectrum.14 
In this study, SMCR was used for NIR imaging data analysis of pharmaceutical 
tablets to investigate their physical property or the mechanism of grinding process.  
Namely, a practical use of SMCR was demonstrated with NIR imaging data of wax 
matrix tablets containing two ingredients, pentoxifylline (PTX) and palmitic acid as 
active ingredient and insoluble excipient, respectively.  Concentration profile of the 
tablets clearly revealed the distribution of the chemical ingredients inside tablets.  The 
distribution of ingredients were strongly related to the grinding time, that is to say, 
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homogenous distribution is clearly proportional to the given grinding time.  It was also 
shown that these distributions apparently corresponded to the release rate of PTX from 
the tablets.  Thus, it is revealed that sustained-release of PTX strongly depends on its 
distribution inside the insoluble waxy matrix.  Consequently, these results clearly 
demonstrate that NIR imaging can be a powerful and versatile tool for the mechanism 
understanding in the manufacturing process of pharmaceutical products and QbD of 
pharmaceutical products becomes possible. 
 
2. Theory 
In this chapter, boldface capital letters are used for matrices, boldface lowercase 
characters are used for vectors, and the superscript T indicates the transpose of matrix.  
 
2.1 Self-modeling Curve Resolution 
If we assume the spectra of a mixture with contributions from A components, a 
general form of SMCR is described as; 
ECSX += T        (1) 
where X  is a data matrix of m spectra recorded at n different wavenumbers. C  is an 
Am×  matrix of pure concentration profiles and S  is a An×  matrix of pure spectral 
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profiles described as follows;  
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Initial estimates can be obtained, for example, by either EFA (Evolving Factor Analysis) 
for C,17, 18 or SIMPLISMA for S.19, 20  The basic principle of SMCR is to seek a 
bilinear model that gives the best fit, in the sense of least squares or weighted least 
squares, to X.  In other words, SMCR estimates pure variables, C and S, minimizing 
the error criterion of sum squared residual (SSR): 
TCSX −=SSR       (4) 
 
2.2 Alternating Least Squares 
ALS (Alternating Least Squares) is an algorithm to minimize the SSR in Eq. (4) with 
two matrices C and S.21, 22  The algorithm comprises a step of iteratively solving two 
alternating least-squares problems, i.e., minimization of Eq. (4) over C for fixed S, as 
well as the minimization of Eq. (4) over S for fixed C.  The solutions of these two 
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minimization problems are given, respectively, by Eqs. (5) and (6).  As a result, the 
basic flow of ALS algorithm is the repetition of the calculation of Eqs. (5) and (6) until 
SSR reaches a minimum value; 
1TS)XS(SC −=        (5) 
1TT C)C(CXS −=       (6) 
Although this iteration process finds mathematically valid solutions, because of 
rotational ambiguities, the solutions must be constrained in order to find chemically 
reasonable solutions.21 
 
2.3 Self-modeling Curve Resolution with Imaging Data 
Spectroscopic imaging system can measure spectra for each pixel of objects.  For 
example, if an object is divided into x × y pixels and spectra are collected at n variables 
for each pixel, imaging data become three dimensional cubic data structure, say 
)( nyx ××  size matrix.  In a practice of SMCR with three dimensional data, spatial 
coordinate of the data are arranged to be two dimensional data structure, such as 
))(( nyx ××  matrix.  SMCR is applied to this arranged X to obtain C and S.  
Consequently, C and ST becomes  ))(( Ayx ××  and )( nA×  matrices, respectively.  
Therefore the concentration of components can be obtained by rearranging 
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))(( Ayx ××  matrix to be )( Ayx ××  size.  Detailed description can be found in 
Ref. 14. 
 
 
3. Experiment 
3.1 Materials 
PTX was purchased from Nakalai tesque, Inc. (Kyoto, Japan).  Chemical structure 
of PTX is shown in Figure 1-1.  Palmitic acid was purchased from Kanto Chemical Co. 
Inc. (Tokyo, Japan).  All reagents were used without further purification. 
3.2 Sample Preparation 
Total 10 g PTX and 40 g palmitic acid were mixed and then ground by a ball mill, 
MONO MILL P-6 (Fritch Japan Co., Tokyo, Japan) containing 50 zirconia balls with 10 
mm diameter.  The sample powder was ground for 0, 0.5, 1, 2, 10 and 45 minutes with 
250 rpm rotating speed.  Finally, for each ground mixture, 200 mg of mixture powder 
was compressed to make a set of tablets using a single punch tablet 
machine equipped with flat-faced punches and a cylindrical die (8 mm i.d.) set at 1000 
kg/cm2. 
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3.3 Near-infrared Imaging 
NIR diffuse reflectance spectra of tablets were collected with a FT-NIR imaging 
system, Spotlight 350 (PerkinElmer, MA, USA) over the 7800-4000 cm-1 region.  NIR 
spectra were measured in 400×400 μm region with a spatial resolution 25 μm/pixel.  
 
3.4 Dissolution Study 
The release profiles of PTX from wax matrix tablets were investigated in accordance 
with the Dissolution Test (Paddle method) of the Japanese Pharmacopoeia XV (JP XV), 
as reported previously.23  Namely, each tablets were dipped into dissolution medium, 
phosphate buffer of pH 6.8, for an hour at 37 °C.  The dissolution medium was 
sampled in an hour and the percent release of PTX was calculated by measuring the 
absorbance at 274 nm by using a ultra-violet and visible spectrophotometric, UV2400 
(Shimadzu Co., Kyoto, Japan). 
 
3.5 X-ray Powder Diffraction Analysis 
Structural changes related to their crystallinity were confirmed with X-ray powder 
diffraction (XRD) of the samples.  XRD profiles of each ground mixture were 
recorded using an X-ray diffractometer, RINT-ULTIMA III (Rigaku Co., Tokyo, Japan).  
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The operating conditions were as follows: radiation, Cu Ka; power, 40 kV × 50 mA; 
automatic monochromator; divergence slit, 1.00 mm; scan mode, continuous mode; 
scan range, 2 - 40˚; scan rate, 4˚/min, scan step. 0.02˚. 
 
3.6 Data Analysis 
First, chemical rank of the whole system is evaluated by singular value 
decomposition.  As shown in Figure 1-2, chemically meaningful rank can be estimated, 
in a mathematical sense, as 2 for each tablet.  It is noted that this number of chemical 
rank 2 corresponds to that of chemical ingredients in each tablet, PTX and palmitic acid.  
Therefore, it can be seen that the system concerning the grinding process is mainly 
described with distribution of PTX and palmitic acid. 
For each tablet, SMCR was applied to the NIR spectra over the spectral region of 
7600 – 4500 cm-1 and concentration profiles C and pure component spectra S were 
obtained.  SMCR requires an initial estimate for C or S.  Several well-known 
methods, EFA for C and SIMPLISMA or OPA for S,20 are usually used for the initial 
estimate.  However, chemical ingredients inside a pharmaceutical tablet are often 
known in many cases of process analysis, and their ‘true’ spectra can be directly 
obtained from the measurement of unmixed samples in advance.  If ingredients have 
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no interaction or structural changes during the grinding process, measured spectra can 
be simply described with linear combination of some coefficients and their ‘true’ spectra 
obtained from the measurement of unmixed samples in advance.  In contrast, if some 
physical or chemical changes are induced to the chemical ingredients by thermal or 
mechanical force given in measurements or sample preparation process, it can not be 
assumed that measured spectra are completely descried just with their ‘true’ spectra of 
pure samples.  For example, if the decrease (or increase) of relative peak intensity or 
the peak shift related to crystallinity occurs in the grinding process, it is not adequate to 
identify pure component spectra with the ‘true’ spectra of unprocessed samples because, 
in this case, the pure component spectra includes the influence by the force given in the 
grinding process.  In other words, the comparison between the ‘true’ spectra of pure 
ingredients and corresponding pure component spectra by SMCR can make it possible 
to reveal the structural change at molecular level induced by the grinding process.  
Therefore, NIR spectra of each individual ingredient were utilized as the initial S.  In 
SMCR, all spectra were normalized and non-negativity constraint was imposed.  All 
calculations were performed by the in-house programs coded in MATLAB (Version 
7.01; The Math Works, USA). 
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4. Results and Discussion 
First, curve resolution performance for each tablet was estimated by a fitting 
parameter, called Lack of Fit (LOF).  LOF, used as an indicator of curve resolution 
performance, is defined as 
100
)ˆ(
LOF
1 1
2
2
×
−
=∑∑
= =
m
i
n
j ij
ijij
x
xx
     (7) 
where ijxˆ  is a reconstructed spectral intensity based on the optimized C and S.  It is 
noted that if the reconstructed spectrum approaches the original, LOF decreases.  In 
other words, LOF is a kind of degree to represent the closeness of the obtained SMCR 
model to the observed chemical phenomena.  Table 1-1 summarizes LOF for each 
tablet.  It is noted that LOF ranges from 0.068 to 3.776 %, resulting relatively small 
resolution errors. 
Figure 1-3(A) and (B) illustrate a series of concentration profiles C of PTX and 
palmitic acid, respectively, for the tablets ground for 0, 2 and 45 minutes.  These 
concentration profiles of the tablets ground for 0 – 45 minutes can be as an index to 
estimate the distribution of PTX and palmitic acid inside the tablets.  As shown in 
Figure 1-3, the ingredients were well-distributed with the increase of grinding time.  
These SMCR results indicate that the grinding time is an important factor for the 
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homogenous distribution of ingredients inside tablets. 
The relationship between the ingredient distribution and the dissolution property can 
also be discussed in this chapter.  Figure 1-4 shows the standard deviation of 
concentration profiles of PTX.  Standard deviation of concentration profiles is given 
as; 
∑
=
−
−
=
m
i
i CCm 1
2)(
1
1
σ      (8) 
where, C is a concentration profiles for a specific chemical component (e.g. palmitic 
acid or PTX) and m corresponds to the number of spectra.  Standard deviation of 
concentration profiles can be a quantitative index representing the distribution of 
chemical ingredients.  For example, if a chemical ingredient distributes homogenously 
inside a tablet, its standard deviation approaches to zero.  As shown in Figure 1-4, the 
standard deviation obviously decreased with the increase of grinding time, which 
showed that PTX was uniformly distributed inside the tablets when enough grinding 
time was given.  Figure 1-5 shows the relationship between the release rate of PTX 
from each wax matrix tablet and the grinding time.  The release rate of PTX decreased 
with the increase of grinding time.  It is noted that the decrease of release rate clearly 
corresponded to the decrease of standard deviation of concentration profiles shown in 
Figure 1-4.  Accordingly, these results suggest that the distribution of PTX particles 
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inside the insoluble waxy matrix is one of the key factors of sustained-release of PTX.  
In the design of pharmaceutical drugs, several pharmaceutical properties such as release 
rate of the ingredient are important indices to control the effect of pharmaceutical drugs 
in the body.  Therefore, it is noteworthy that the estimate of release rate by NIR 
imaging may become possible since release rate is clearly related to standard deviation 
of concentration profiles. 
Figure 1-6 represents optimized S for PTX over the spectral region of 7600 – 4500 
cm-1.  Black line represents the pure spectrum of PTX.  Blue and red lines represent the 
pure spectra of tablets ground for 0.5 and 45 minutes, respectively.  It is interesting to 
point out that there are some differences between the initial and optimized S in Figure 
1-6.  If there were no structural change in the mixtures and no interaction among the 
ingredients, the NIR spectra of the tablets could be described simply as a linear 
combination of the pure spectra of individual chemical ingredients.  Namely, in this 
case, each optimized S would become equal to each initial S obtained directly from the 
measurement of unmixed samples in advance.  On the other hand, if there is a true 
chemical or physical change in the ingredients upon grinding, the optimized S may be 
altered and show some difference compared to its original pure component spectrum.  
Accordingly, the difference between the initial and optimized S can provide useful 
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information, which is not described just by the spectra of pure ingredients.  In our case, 
the comparison of S from each tablet indicated a sequential change of S caused by the 
physical force given in the grinding process.  In Figure 1-6, peaks in the region of 
6300 – 5500 cm-1 clearly decreased with the increase of grinding time.  These peaks 
are assigned to the overtone and combination modes of -CH groups of PTX.  For 
example, a peak at 5830 cm-1 is due to the first overtone of antisymmetric stretching 
mode of CH2 group.  The difference between the initial and optimized S is most 
probably due to that chemical interaction caused by grinding process.  The spectral 
difference between initial and optimized S or among S, for example, indicates their 
structural change related to polymorphs or amorphous properties induced by the 
grinding process.  The NIR spectra of separately ground PTX showed the decrease in 
peaks in the region of 6300 – 5500 cm-1.  This result supports that the optimized S 
indicates the change of PTX caused by grinding process.  This kind of use of SMCR 
analysis applied to the sequentially perturbed system can be a useful tool to reveal the 
detailed effect of the thermal or mechanical force given in the manufacturing process 
which causes stepwise or continuous change in C and S. 
On the other hand, XRD profiles indicated the decrease of crystallinity of PTX.  As 
shown in Figure 1-7, the intensity of PTX peaks at 7.5˚, 13.6˚, and 15.2˚ (2θ) 
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decreased with the grinding time.  This result supports the observation obtained with 
the initial and optimized S by SMCR.  Namely it clearly corresponds to the crystal 
structure change of PTX related to CH group, say probably hydrogen bonding.  
Decreases in crystallinity of ingredients generally induce the enhancements in their 
solubility. On the contrary in this study, the solubility ratio of PTX was restrained 
though its crystallinity decreased.  These results suggest that decrease in the solubility 
ratio may be related to the distribution of the ingredient.  For example, if PTX 
molecules are covered with hydrophobic palmitic acid, it can prevent the contact with 
water.  On the other hand, the result reveals the presence of a specific change of PTX 
crystalline structure.  Thus, its crystallinity decrease may also be another key factor of 
sustained-release of PTX.  Consequently, it indicates the possibility and utility that 
NIR imaging combined with SMCR enables one to reveal the change of crystallinity or 
crystal structure of ingredients without using XRD. 
 
 
5. Conclusion 
The NIR imaging analysis of pharmaceutical tablets containing PTX and palmitic 
acid was demonstrated in this study.  A chemometrics technique called SMCR was 
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applied to the NIR imaging data of the tablets to extract qualitative and quantitative 
information.  Concentration profiles obtained by SMCR revealed that PTX was 
well-distributed in the waxy matrix of tablet with the increase of grinding time.  On the 
other hand, pure component spectra by SMCR apparently indicated a sequential change 
of crystal structure of PTX induced by the grinding process.  Thus, these results imply 
that following two factors are strongly related to sustained-release of PTX: the 
distribution of PTX particles inside the insoluble waxy matrix; and the crystal structure 
change of PTX which may be based on intermolecular hydrogen bonding induced by 
the manufacturing process.  Consequently, this study has demonstrated that it is 
possible to reveal both distribution uniformity and molecular structure change of the 
ingredients by NIR imaging combined with SMCR analysis.  It can be a powerful and 
versatile tool for the mechanism understanding in the manufacturing process of 
pharmaceutical products.  This tool would surely prompt QbD of pharmaceutical 
products. 
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Table 1-1 LOF for each tablet 
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Figure 1-1 Chemical structure of PTX 
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Figure 1-2 Chemical rank estimate by singular value decomposition 
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Figure 1-3 Concentration profiles C of (A) PTX and (B) palmitic acid for each tablet 
ground for 0, 2 and 45 minutes 
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Figure 1-4 A plot of grinding time versus standard deviation of concentration profiles 
C of PTX 
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Figure 1-5 Relationship between percent released and grinding time for each tablet 
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Figure 1-6 Pure component spectra S and pure spectrum of PTX 
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Figure 1-7 XRD profiles of mixtures of PTX and palmitic acid ground for (A) 0, (B) 2, 
(C) 10 and (D) 45 minutes 
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Chapter 2 
 
An Effect of Cellulose Crystallinity on 
Moisture-absorbability of a Pharmaceutical 
Tablet Studied by Near-infrared Spectroscopy 
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Abstract 
In this study, we investigated molecular level variation of tablets caused by grinding 
and its effect on moisture-absorbability of the tablets.  Model tablets contained 
acetaminophen (AAP) as an active pharmaceutical ingredient and microcrystalline 
cellulose (MCC) as an excipient.  Different level of grinding was applied to MCC prior 
to tablet formulation, to intentionally cause structural variation in the MCC.  The 
moisture-absorbability of tablets showed obvious variation depending on the grinding 
time, and the corresponding change in near-infrared (NIR) spectra was readily captured.  
The detailed analysis of the variation of the band frequencies (i.e. wavenumber) 
revealed that the grinding process substantially disintegrates the crystalline and 
generates glassy amorphous structure of MCC, which is a requirement to absorb water 
molecules.  Consequently, it is very likely that the change of the moisture-absorbability 
of the tablets is closely related to the development of the amorphous structure.  These 
results indicate that the pharmaceutical product performance can be influenced by the 
physical properties of the excipient, which, in turn, can be controlled by the grinding 
process. 
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1. Introduction 
In the formulation design of pharmaceutical products, the adequate administration 
route and dosage form are chosen with consideration for physical, chemical, and 
biochemical properties of an active pharmaceutical ingredient.  In some cases, the 
site-specific drug release property is designed in order to deliver the active ingredient to 
a target organ efficiently.1-3  In other cases, the oral disintegration or controlled-release 
is desirable for improvement of patient compliance and convenience.1, 4-6  Suitable 
excipients and formulation are selected for desirable pharmaceutical product 
performance.7-9  Additionally, it is important to note that the pharmaceutical tablet 
performance such as dissolution, disintegration, moisture-absorbability, and stability has 
effects on the bioavailability and quality of the tablet.  It is known that the tablet 
performance is affected by the density and surface condition of the tablet.10, 11  The 
tablet performance is also closely related to the physical properties, especially crystal 
structure, of active pharmaceutical ingredient and excipient in the tablet.12-16  The 
crystal structure of active pharmaceutical ingredient is strictly controlled during the 
manufacturing processes.  On the other hand, the crustal structure of excipient is often 
overlooked.  The excipients have a crucial role to create desirable product performance.  
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Therefore, it is important to control the physical properties of excipient in a 
pharmaceutical product. 
The so-called mechano-chemical effect is structural variation of chemical 
components caused by thermal or mechanical force provided during some 
manufacturing processes.17  Microcrystalline cellulose (MCC) is a well-known 
excipient commonly included in pharmaceutical tablets as diluent, binder, and 
disintegrator.7-9  It is known that the polymeric structure of MCC is influenced by 
specific manufacturing process and the change in the polymeric structure eventually 
results in the variation of the pharmaceutical property of the tablet.18  For example, we 
reported that the compression can induce the disintegration of crystalline structure of 
MCC.  The development of the mobile amorphous component by the compression 
makes it possible to pack the tablet tightly, which eventually results in the delay in the 
dissolution and moisture-absorption.18  In addition, the development of the disordered 
amorphous structure results in the variation of the pharmaceutical property since the 
amorphous component tends to absorb even more water molecules.19, 20  Thus, the 
clarification of the polymeric structure change of MCC leads to penetrating insight into 
the manufacturing process, which, in turn, can be useful for the control of the 
pharmaceutical product performance.  
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Vibrational spectroscopy, infrared (IR), near-infrared (NIR), and Raman 
spectroscopy, has frequently been used for exploration of the physical properties of 
formulation components in pharmaceutical products.21-26  In particular, NIR 
spectroscopy has significant light penetration property.  It provides an interesting 
opportunity to elucidate the physical and chemical information inside pharmaceutical 
products, i.e. tablets.27-31  Also, NIR spectrum is more sensitive to the change in the 
hydrogen bonding, compared to IR spectroscopy and Raman spectroscopy and, 
therefore, it enables one to sort out molecular-level variations of the sample.  
Consequently, NIR spectroscopy is a powerful tool for the evaluation of the polymeric 
structure of MCC inside products.  In fact, in our previous study we investigated the 
molecular-level variations of MCC, i.e. crystalline structural variations, by using NIR 
spectroscopy.32 
In this study, we explored an effect of grinding of MCC on transient variation 
induced by storage of tablets.  For example, the grinding may induce substantial 
changes in the cellulosic polymeric structure.  When stored under the presence of 
water molecule, the development of such structure possibly brings the transient 
variation which may, in turn, affect the pharmaceutical property of the tablet containing 
MCC.  We prepared the model tablets containing acetaminophen (AAP) as an active 
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pharmaceutical ingredient and MCC as an excipient.  The MCC was subjected to 
grinding treatment prior to tablet formulation, and then the tablets containing MCC 
were stored for relatively long period (i.e., 3 months) to intentionally cause structure 
variation of the cellulose structure depending on the level of the applied grinding.  The 
moisture-absorbability of stored tablets showed an obvious variation depending on the 
grinding time.  Substantial changes in the NIR spectral features were also observed 
when the MCC went through the grinding.  The positional shifts of the crystalline and 
amorphous peaks revealed that the grinding process substantially disintegrated the 
crystalline and generated glassy amorphous structure of MCC.  Additionally, the 
molecular level findings derived from NIR spectra and morphological information from 
scanning electron microscopy (SEM) lead to comprehensive picture of the system 
alternation caused by the storage for 3 months.  These results indicate that the 
molecular-level variation of excipient induced by the grinding changes the 
pharmaceutical product performance, which, in turn, can be controlled by the grinding 
process. 
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2. Experiment 
2.1 Materials 
MCC, CEOLUS® (PH-101), was purchased from Asahi Kasei Chemicals Co., (Tokyo, 
Japan).  AAP, 4-acetamidophenol, was purchased from Tokyo Chemical Industry Co., 
Ltd. (Tokyo, Japan).  All reagents were used without further purification.  Their 
chemical structures are shown in Figure 2-1. 
 
2.2 Sample Preparation 
Ground MCC samples were prepared by a vibration sample mill, TI-100 (Cosmic 
Mechanical Technology Co., Ltd., Fukushima, Japan), fitted with a porcelain rod for 0, 
20, 40, and 60 minutes, respectively.  Total 1 g AAP and 4 g ground MCC were mixed.  
Then 200 mg of the mixture powder were compressed to make a set of tablet with a 
manual tableting machine, HANDTAB-100 (Ichihashi-Seiki Co., Ltd., Kyoto, Japan), at 
a fixed pressure level, and several tablets were made per grinding condition.  The 
powder was placed inside the die of 8 mm diameter.  The 10 kN pressure was 
gradually applied to the upper punch to circumvent the generation of unwanted 
frictional heat.  Pressure was released immediately after reaching 10 kN.  No 
lubricant was used for the compression.  The samples were handled under the constant 
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temperature and relative humidity kept at approximately 24˚C and 60%, respectively. 
 
2.3 Moisture-absorption Analysis 
The moisture-absorption analysis was carried out using tablets stored for three 
months under the usual laboratory conditions, approximately 24˚C and non-controlled 
humidity.  The tablets were dried with a vacuum drying oven, DP23 (Yamato 
Scientific Co., Ltd., Tokyo, Japan), for 48 hours at 25˚C.  Then, each tablet underwent 
moisture absorption experiment by a moisture sorption analyzer, IGAsorp (Hiden 
Isochema Ltd., Warrington, UK) (N = 1).  The increase in the weight caused by the 
transient moisture-absorption was monitored at the fixed temperature 25˚C and relative 
humidity 95%. 
 
2.4 X-ray Computed Tomography 
X-ray computed tomography (CT) images of the tablets were scanned by a X-ray 
computed tomograph equipment, SKY SCAN 1172 (Bruker microCT, Kontich, 
Belgium) equipped with Cu tube, with a spatial resolution of 5.5 µm and rotation step of 
0.40° (N = 1).  The X-ray sauce was operated with a tube voltage of 60kV and current 
of 100 µA. 
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2.5 Scanning Electron Microscopy 
Scanning electron microscopy (SEM) photographs of the ground MCC and the tablet 
surface were taken with a scanning electron microscope, SU 1510 (Hitachi 
High-Technologies Co., Tokyo, Japan) (N = 1).  The ground MCC was coated with a 
palladium gold layer using an ion sputter, E-1010 (Hitachi High-Technologies Co., 
Tokyo, Japan), with 15mA for 120 seconds.  The tablets were measured without 
sputtering after 3 months’ storage under the usual laboratory conditions, approximately 
24˚C and non-controlled humidity.  
 
2.6 Near-infrared Spectroscopy 
NIR diffuse reflectance spectra of the tablets were collected by a FT-NIR imaging 
system, Spotlight 350 (PerkinElmer, Inc., MA, USA) over the 7500 – 5500 cm-1 region 
(N = 1).  Note that the tablets were measured without further vacuum drying before the 
storage.  NIR spectra were measured in 500 × 500 µm region of the tablet surface with 
a spatial resolution 25 µm/pixel for each tablet, which resulted in approximately 450 
spectra per a tablet.  Each spectrum was collected with a 16 cm-1 resolution by 
co-adding 64 scans.  A background spectrum was measured with a gold film. 
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2.7 X-ray Powder Diffraction Analysis 
X-ray powder diffraction (XRD) profiles of the ground MCC were recorded using an 
X-ray diffractometer, RINT-ULTIMA III (Rigaku Co., Tokyo, Japan).  The diffracted 
intensity under Cu Ka radiation (40 kV and 50 mA) was measured with scan range of 5 
- 40° and scan step of 0.02° at scan rate of 2°/min. 
 
 
3. Results and Discussion 
3.1 Moisture-absorbability of Tablets 
Water absorption to the tablets was measured by the moisture-absorption analysis.  
The analysis was carried out using tablets stored for three months under the usual 
laboratory conditions.  The moisture-absorbability of each tablet is shown in Figure 
2-2.  When exposed to the controlled atmosphere, the tablet started to absorb water 
molecules to increase its relative weight.  The way for the tablet to absorb water is 
essentially influenced by the physical or chemical property of the tablet.  For example, 
one can find that the relative weight of each tablet showed an obvious increase at the 
onset of the measurement.  Of note is that the absorption of the water became even 
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more pronounced with the grinding.  The grinding mostly induced the substantial 
change in MCC and it led to a variation of the water-absorption behaviors. 
It is important to point out here that the grinding process essentially works to 
pulverize the particles, the particle size of MCC, thus, can be reduced by grinding.  For 
example, Figure 2-3 shows SEM images of the MCC powder samples.  Brightly-lit 
clumps in the figures represent massively coagulated MCC particles.  It is noted that 
the size of the clump was clearly decreased with the application of the grinding.  It is, 
thus, likely that the particles were pulverized by the grinding.   
The effect of the grinding on the tablet density was explored by X-ray CT.  Figure 
2-4(a) shows top-view images of inside of tablets by X-ray CT.  The brightness of CT 
image reflects a difference in the density of material.  The gray level of each pixel in 
the CT images corresponds to the X-ray attenuation, which reflects the proportion of 
X-ray scattered or absorbed as it passes through each voxel.33  X-ray attenuation is 
primarily a function of X-ray energy along with the density and composition of the 
material.  For example, dark pixels in Figure 2-4(a) represent low density region, and 
brighter pixels, in contrast, represent high density region.  Thus, the X-ray CT images 
reflect a difference in the tablets density.  It is important to note that, seemingly, no 
significant difference in the color can be found between the images, suggesting no 
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specific difference in the density.  Such observation becomes even more obvious when 
one look at the porosities of the images.  Figure 2-4(b) shows the porosities estimated 
by binarization of three-dimensional images.  Note that the porosity, defined as the 
ratio of pixels having binary value 0 or 1, was calculated after the binarization with a 
threshold set to be one- fifth of the maximum intensity of the image.  Interestingly, no 
significant difference in the porosities of tablet can be observed regardless of MCC 
grinding time as excepted.  In fact, the corresponding weights and volumes of the 
tablets provided also less significant differences (data not shown).  It is, thus, likely 
that the particle size reduction by grinding does not provide substantial change in the 
tablet density.  
Figure 2-5 shows SEM images of the tablet surfaces.  Note that the SEM 
observation was carried out using tablets stored under the same condition as tablets used 
in moisture-absorption analysis, i.e. three months’ storage under the usual laboratory 
conditions.  Comparison of these SEM images provides useful information about the 
difference in the surface morphology between the tablets.  For example, one can find 
that the several cracks appeared on the tablet containing MCC ground for 40 minutes.  
Importantly, the cracks on the tablet containing MCC ground for 60 minutes then 
propagated over the entire surface and became even more significant.  The 
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development of the cracks is mostly explained as spontaneous swelling of the tablets.  
After the manipulation of the tablet, the tablet gradually started to absorb atmospheric 
moisture.  The excessive increase in the volume by the swell often generates cracks on 
the surface of the tablet.  The development of such rough surface was followed by the 
penetration of the water molecules into the matrix and thus accelerated water absorption.  
Consequently, the grinding is more or less associated with the surface roughness, which, 
in turn, affects the moisture-absorption of the tablet.  
Altogether, it is likely that the difference in the moisture-absorbability is closely 
related not to the density but to the structure change of MCC induced by the grinding.  
While above observation reveals macroscopic picture of the system, unfortunately, the 
moisture-absorption and SEM images do not provides any useful information on the 
molecular-level alternation essentially governing the change in the actual 
pharmaceutical property of the tablets.   
 
3.2 Molecular-level Variation of Ground Microcrystalline Cellulose in Tablets 
So far, it has been revealed that the grinding induced significant variations of the 
morphology of the tablets and it eventually affected the moisture-absorbability.  Thus, 
the analysis of the corresponding NIR spectra becomes especially important to derive 
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in-depth understanding of the variation caused during the storage.  It should be pointed 
out that the spectra were measured before the storage for 3 months.  After the storage, 
the tablet showed different morphological and pharmaceutical variation depending on 
the grinding time.  Thus, the analysis of the NIR spectra of the tablet before the storage 
may provide key information about the origin of the observed alternation caused during 
the storage.  The average spectra derived from the each tablet are shown in Figure 
2-6(a).  The pure spectra of the AAP and MCC are presented for reference in Figure 
2-6(b).  The peaks observed in this region are specific to the vibration modes of AAP 
and MCC.  For example, the peak at 6970 cm-1 is assignable to the first overtone of the 
OH stretching mode of OH groups in the amorphous region of MCC with weak 
hydrogen bonds.34  The peak at 6300 cm-1 is ascribed to hydrogen-bonded OH groups 
in the crystalline region of MCC.34-36  The peak at 6395 cm-1 is probably assignable to 
the first overtone of the OH stretching mode of AAP.37  In Figure 2-6(a), a significant 
increase of the spectral intensity was observed in the whole range of the NIR region 
with grinding.  This may be explained as the increase of the light scattering, which 
eventually brings the baseline fluctuation.  It is also important to note that the peaks in 
Figure 2-6(a) were embedded by the overlap, making the identification of the intensity 
variation caused by the grinding obviously difficult.  The second derivative is often 
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useful to elucidate meaningful variation of spectral intensity by removing the unwanted 
baseline change and resolving the overlapped feature of an NIR spectrum.  For 
example, Figure 2-6(c) represents the second derivative spectra calculated from the 
spectra in Figure 2-6(a).  Now one can find that the spectra were free from the 
intensity variation arising from the scattering.  It is also noted that the peaks were 
clearly resolved, enabling to sort out the intensity variation by the grinding.  In Figure 
2-6(c), the amorphous peak at 6970 cm-1 became much larger negative value when the 
grinding is applied.  Such change in the intensity can be explained as the gradual 
increase in the content of the amorphous structure.  In contrast, the increase in the 
intensity of the crystalline peak at 6300 cm-1 indicates that the grinding decreases the 
quantity of the crystalline structure.  It is also interesting to point out here that the AAP 
peak at 6395 cm-1 also showed an obvious variation of the spectral intensity, while the 
AAP in the tablets did not undergo the grinding treatment.  Such change in the AAP 
peak may be interpreted to mean that the increased surface roughness scattered the NIR 
light and prevented its penetration and, thus, it finally provided an apparent variation of 
the quantity of the AAP as well as MCC in the tablets depending on the grinding time.  
Consequently, it is very likely that the change of the spectral intensity reflects not only 
the change in the concentration but the change in the light scattering.  Since the 
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densities of the tablets were equivalent regardless of MCC grinding time, it is 
reasonable to conclude that the difference in surface roughness of the tablets caused the 
unwanted fluctuation of the spectral intensity and, unfortunately, the fluctuation can not 
be removed completely even though the spectrum is subjected to second derivative.  
Such observation indicates that the assumption, that the change in the spectral intensity 
purely reflects the structural variation of the crystalline structure of the MCC, is now on 
a very shaky ground.  Alternative analytical approach which does not depend on the 
spectral intensity is required.  
Physical transitions of components usually result in the systematic alteration of 
vibrational spectroscopic features.38  Vibrational frequency for a diatomic molecule 
can be described as a function of reduced mass and bonding force constant, which is a 
measure of the strength or rigidity of a chemical bond in its normal equilibrium 
position.32,39  For example, the degree of molecular-level interactions such as hydrogen 
bonding often influences the band position of a vibrational spectrum.  The 
development of crystalline structure consisting of the hydrogen bonding between 
adjacent polymer chain results in the decrease in the force constraint of OH bonds.  
Consequently, the increase in the degree for hydrogen bonding can be observed as a 
band position shift in the lower wavenumber direction.  Thus, a substantial change in 
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molecular structure in turn can be readily detected as a form of band position shift such 
as a red or blue shift.  Importantly, the change in the band potion shift is less 
influenced by the variation of the spectral intensity.  It becomes possible to extract the 
key information concerning the structural alternation of the system without being 
hampered by the fluctuation of the spectral intensity.32, 39  For example, peak positions 
concerning the crystalline band observed over the entire surface plane of the tablet 
ground for (a) 0 and (b) 60 minutes are shown in Figure 2-7.  Note that the intensities 
at each coordinate (X- and Y-axis) means the wavenumber where the peak maximum is 
observed.  The wavenumber of the band position was estimated in more detail by zero 
crossing points of third derivative of the raw spectra with data interpolation.  The main 
motivation of using third derivative here is to enhance spectral resolution by 
mathematical treatment based on zero crossing technique.32  It can enhance small level 
of a band shift (e.g. less than spectral resolution) which cannot be readily detected in a 
typical stack of one dimensional spectrum.  Comparison of the figures reveals that the 
entire plane shown in Figure 2-7(a) was mainly covered with darker color, suggesting 
most of the crystalline bands were located at the lower wavenumber positions.  The 
entire plane shown in Figure 2-7(b), in contrast, was filled with the brighter color, 
revealing the band positional shift to the higher wavenumber direction.  Since the 
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frequency shift to the higher wavenumber can be interpreted as substantial decrease of 
molecular interaction, i.e. crystalline structure, the result can be explained as the 
disintegration of the crystalline component.  Figure 2-8 represents the averages and 
standard deviations of band positions of (a) crystalline and (b) amorphous peak derived 
from the every individual tablet.  As expected, the crystalline peaks obvious shifted to 
the higher wavenumber direction due to the disintegration of the ordered structure.  
The amorphous peak, in contrast, gradually shifted to the opposite direction, suggesting 
increase in the population of the disordered (i.e., less interacted) structures.  Such shift 
in the opposite manner can be interpreted as the development of the glassy amorphous 
component.  It is, therefore, likely that the grinding disintegrates the crystalline 
structure of the MCC and the decrease in the crystalline content is compensated by the 
development of the disordered amorphous structure.   
Such conclusion derived from the analysis of the NIR spectra is clearly supported by 
the XRD patterns of the MCC powder samples shown in Figure 2-9(a).  The crystalline 
structure of cellulose provided distinct peaks at 15°, 16.4° and 22.5°.  While it was not 
clearly observed in the XRD pattern, it is known that the amorphous component also 
generates a halo peak around 21°.40  The peaks at 15°, 16.4° and 22.5° showed a 
gradual decrease and, in contrast, the halo peak showed increase with the grinding.  It 
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mostly reflects the fact that the crystalline structure was disintegrated by the grinding 
and this was followed by the development of disordered amorphous structure.  The 
crystallinity of MCC powder calculated from the XRD patterns is shown in Figure 
2-9(b).  Note that the crystallinity was calculated as the ratio of the crystalline and 
amorphous components by using a curve-ﬁtting method.40  As expected, the 
crystallinity showed a gradual decrease with the grinding.  This result agrees with that 
derived from the band shift analysis of NIR spectra. 
 
3.3 The Effect of Crystallinity of Microcrystalline Cellulose on Moisture- 
absorbability of the Tablets 
Now the results derived from above observations brought together provide an 
inserting opportunity to derive a more comprehensive picture of the system.  MCC 
consists of crystalline and disordered amorphous structures.  Some mechanical forces 
essentially disintegrate the crystalline structure and generates mobile amorphous.  The 
crystalline structural change of MCC may affect the way to absorb water molecules 
because the ability for MCC to absorb water is closely related to its polymeric structure.  
In fact, we revealed that the amorphous component of MCC tends to bind water 
molecules more strongly than the crystalline component.41  It now becomes obvious to 
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consider the importance of the grinding.  In our case, the visual inspection of Figure 
2-7 clearly reveals that the grinding disintegrated the crystalline structure and generated 
amorphous component over the entire surface plane of the tablets.  The predominant 
development of the amorphous should be followed by the spontaneous absorption of 
even more water molecules during the storage.  The swelling caused by the water 
absorption generated the rough surface on the tablet, which, in turn, increased the 
moisture-absorbability of tablet.  Consequently, it can be concluded that the 
disintegration of crystalline structure of MCC by grinding process decreased the 
physical stability of the tablets and subsequently increased the moisture-absorbability of 
tablet.  These results are useful for the control of the pharmaceutical product 
performance by grinding process. 
 
 
4. Conclusion 
In this study, we investigated an effect of grinding on moisture-absorbability of 
tablets containing MCC.  The ability for the tablets to absorb water molecules was 
increased depending on the grinding of MCC.  The SEM observation of the tablet 
surface indicated that the increased roughness of tablet surface by the swelling 
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accelerated the penetration of water molecules into the tablet.  Then, the variation of 
polymeric structure of the MCC induced by the grinding was explored by NIR 
spectroscopy.  NIR spectra analysis based on band position shift provided key 
information related to the crystalline structure of MCC in tablets.  Namely, it was 
revealed that the grinding process substantially disintegrated the crystalline and 
generated the glassy amorphous structure of the MCC over the entire surface plane of 
the tablet.  The predominant development of the amorphous should be followed by the 
spontaneous absorption of even more water molecules when exposed to the open 
atmosphere for relatively long period.  The water absorption swelled the tablet and 
generated the rough surface on the tablet, which, eventually, increased the 
moisture-absorbability of the tablet.  These results indicate that the pharmaceutical 
product performance can be influenced by the physical properties of the excipient, 
which, in turn, can be controlled by the grinding process. 
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Figure 2-1 Chemical structures of (a) cellulose and (b) acetaminophen (AAP) 
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Figure 2-2 Moisture-absorption by the tablets containing MCC ground for 
(continuous line) 0, (dotted line) 20, (dashed line) 40, and (dashed-dotted 
line) 60 minutes 
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Figure 2-3 SEM images of MCC powder ground for (a) 0, (b) 20, (c) 40, and (d) 60 
minutes 
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Figure 2-4 (a) X-ray CT images of the tablets ground MCC and (b) the porosities of 
tablets estimated by three-dimensional image of X-ray CT 
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Figure 2-5 SEM images of the tablets containing MCC ground for (a) 0, (b) 20, (c) 40, 
and (d) 60 minutes 
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Figure 2-6 (a) NIR spectra of the tablets containing MCC prepared under varying 
grinding time, (b) NIR spectra of (continuous line) AAP and (dotted line) 
MCC, and (c) second derivative spectra calculated from the spectra in 
Figure 6(a) 
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Figure 2-7 Peak position of crystalline band on tablets ground for (a) 0 and (b) 60 
minutes 
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Figure 2-8 Band position shifts of (a) the crystalline and (b) amorphous peaks derived 
from every single tablet 
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Figure 2-9 (a) XRD patterns of MCC powder prepared under varying grinding time, 
(b) Crystallinity of MCC powder calculated from the XRD patterns 
82/139 
 
 
Chapter 3 
 
The Effect of Microcrystalline Cellulose 
Crystallinity on Moisture-absorbability, 
Water-penetration and Stability of 
Pharmaceutical Tablets 
 
83/139 
 
Abstract 
The crystal structures of active pharmaceutical ingredients and excipients influence 
the properties of pharmaceutical products such as dissolution, disintegration, 
moisture-absorbability, and stability.  Crystal structures may cause substantial changes 
in the quality and bioavailability of pharmaceutical products.  In this study, we 
investigated the effects of microcrystalline cellulose (MCC) crystallinity on the 
water-penetration, moisture-absorbability and stability of aspirin (ASA) and 
acetaminophen (AAP) tablets containing 20% MCC as an excipient.  Different levels 
of grinding were applied to MCC prior to tablet formulation, to intentionally cause 
structural variation in the MCC.  The water-penetration and moisture-absorbability of 
the tablets increased dependant on the grinding time even when the tablets contained 
only 20% MCC.  More importantly, for the ASA tablets, the hydrolysis of ASA was 
also accelerated.  That is to say, the decrease in the crystallinity of MCC induced by 
grinding decreased the stability of these tablets.  These results indicate that the 
crystallinity of MCC has crucial effects on product performance.  Therefore, 
controlling the crystal structure of excipients in the manufacturing process is important 
for controlling product qualities. 
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1. Introduction 
It is well-known that the crystal structure of an active pharmaceutical ingredient 
affects its solubility, moisture-absorbability, and stability, which in turn influence the 
bioavailability of pharmaceutical products.1-5  Therefore, the crystal structures of 
active pharmaceutical ingredients are, in general, strictly controlled in the 
manufacturing process of pharmaceutical products.  However, the crystal structures of 
excipients also affect pharmaceutical product performance.  For example, Ando et al. 
revealed that the amorphous content of sucrose changed the hardness and 
water-penetration of tablets stored for a certain period.6  Sebhatu et al. reported that 
tablets containing lactose had different hardness dependant on the amount of amorphous 
lactose.7  Consequently, it is most likely that the crystallinity of excipients can affect 
pharmaceutical product performance, and so should be, in turn, strictly controlled in the 
manufacturing process. 
In our previous study we revealed that a decrease in the crystallinity of 
microcrystalline cellulose (MCC), a well-used pharmaceutical excipient, made it 
possible to pack the tablet tightly, which resulted in a delay in dissolution.8  We also 
reported that the development of the mobile amorphous component increased the 
moisture-absorbability of tablets.9  The variation of the crystalline structure of MCC 
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also affects the hardness and dissolution profile of tablets.10  The disordered 
amorphous structure of MCC can bind the water molecule more strongly than the 
crystalline structure.11, 12  It is possible that the variation of crystallinity of MCC 
induces changes in the pharmaceutical product performance.  In fact, it is known that 
the crystallinity of MCC can be decreased by some manufacturing processes (e.g. the 
grinding process and compression process).13, 14  Such disintegration of the crystalline 
structure is compensated by the development of amorphous component which 
eventually affects the pharmaceutical property of MCC tablets.  However, the tablets 
used in these studies were constructed mainly from MCC, using 80 – 90% of MCC.8-10  
While the analysis of such MCC tablets provides useful background information about 
variation in the supermolecular structure of MCC, the detailed mechanism, especially 
for actual pharmaceutical tablets containing a much smaller amount of MCC, is not 
fully understood yet. 
In this study, tablets containing 20% of MCC, 20 % of an active pharmaceutical 
ingredient (either acetaminophen (AAP) or aspirin (ASA)), and 60% of other excipients 
were used to investigate the actual effects of MCC crystallinity on tablet performance.  
MCC was ground before tablet formulation to intentionally cause a decrease in 
crystallinity.  The water-penetration into and moisture-absorbability of tablets 
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increased with grinding time, i.e. increased with the decrease in the crystallinity of 
MCC.  More importantly, the hydrolysis of ASA inside tablets was accelerated 
proportionately to the grinding time of MCC when the tablets were stored under high 
humidity conditions.  That is to say, the decrease in the crystallinity of MCC, induced 
by grinding, decreased the stability of tablets which is one of the most important 
properties for tablet performance.  These results indicate that the crystallinity of MCC 
has crucial effects on the product performance even when the tablets contain a relatively 
small amount of MCC. 
 
 
2. Experiment 
2.1 Materials 
Acetaminophen (AAP), 4-Acetamidophenol, was purchased from Tokyo Chemical 
Industry Co., Ltd. (Tokyo, Japan).  Aspirin (ASA), 2-Acetylsalicylic acid, was 
obtained from Nacalai Tesque,Inc. (Kyoto, Japan).  Microcrystalline cellulose (MCC), 
CEOLUS® (PH-101), was purchased from Asahi Kasei Chemicals Co. (Tokyo, Japan). 
Anhydrous dibasic calcium phosphate (DCPA), Fujicalin®, was purchased from Fuji 
Chemical Industry Co., Ltd. (Toyama, Japan).  Their chemical structures are shown in 
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Figure 3-1.  Stearic acid magnesium salt (Mg-St) was purchased from Taihei Chemical 
Industrial (Osaka, Japan).  All reagents used as formulation components were used 
without further purification.  All regents used for mobile phase of liquid 
chromatography were high-performance liquid chromatography grade.  The other 
reagents were analytical grade. 
 
2.2 Sample Preparation 
AAP tablets containing AAP, MCC, DCPA and Mg-St for the water-penetration 
analysis and the moisture-absorbability analysis were prepared as follows: AAP 
(20wt%), unground MCC or ground MCC (20wt%), DCPA (60wt%), and Mg-St 
(0.2wt%) were mixed.  Ground MCC samples were prepared by grinding for 20, 40, 
and 60 minutes, respectively, with a vibration sample mill, TI-100 (Cosmic Mechanical 
Technology Co., Ltd., Fukushima, Japan), fitted with a porcelain rod.  200 mg of the 
mixed powder were compressed to make a set of tablets with a manual tableting 
machine, HANDTAB-100 (Ichihashi-Seiki Co., Ltd., Kyoto, Japan), at a fixed pressure 
level, and several tablets were made per grinding condition.  The powder was placed 
inside an 8 mm diameter die.  The 10 kN of pressure was gradually applied to the 
upper punch to circumvent the generation of unwanted frictional heat.  Pressure was 
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released immediately after reaching 10 kN.  The samples were handled at 
approximately 25˚C and 75% relative humidity. 
ASA tablets containing ASA, MCC, DCPA and Mg-St, for the stability studies were 
prepared as follows: ASA (20wt%), unground MCC or ground MCC (20wt%), DCPA 
(60wt%), and Mg-St (0.2wt%) were mixed. Ground MCC samples were prepared by 
grinding for 20, 40, 60, and 90 minutes, respectively, with a vibration sample mill fitted 
with a porcelain rod.  A set of tablets was prepared by the same process described 
above, and several tablets were made per grinding condition.  The samples were 
handled at approximately 25˚C and 40% relative humidity. 
 
2.3 X-ray Powder Diffraction Analysis 
X-ray powder diffraction (XRD) profiles of the ground MCC were recorded with an 
X-ray diffractometer, RINT-ULTIMA III (Rigaku Co., Tokyo, Japan).  The diffracted 
intensity under Cu Ka radiation (40 kV and 50 mA) was measured with a scan range of 
5 - 40° and scan step of 0.02° at scan rate of 2°/min. 
 
2.4 Water-penetration Analysis 
Tablets were placed on a 55 mm diameter filter paper soaked with 500 µL of water, 
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and then the amount of time for water to penetrate the entire tablet was measured (N = 
3).  Penetration time per unit volume was defined as: Penetration time per unit volume 
(sec/mg/mm3) = [the time for water to penetrate entire tablet (sec)] / [the density of the 
tablet (mg/mm3)].  The densities of the tablets used in water-penetration analysis were 
calculated in advance using their weights, diameters, and thicknesses.  The control 
tests were also performed using chloroform instead of water (N = 3).   
 
2.5 Moisture-absorption Analysis 
Tablets were dried with a vacuum drying oven, DP23 (Yamato Scientific Co., Ltd., 
Tokyo, Japan), for 48 hours at 25˚C.  Then, each tablet underwent moisture absorption 
analysis by a moisture sorption analyzer, IGAsorp (Hiden Isochema Ltd., Warrington, 
UK) (N = 1).  The increase in weight caused by the transient moisture-absorption was 
monitored at a fixed temperature 25˚C and 95 % relative humidity. 
 
2.6 X-ray Computed Tomography 
X-ray computed tomography (CT) images of the tablets were scanned with a SKY 
SCAN 1172 (Bruker micro-CT, Kontich, Belgium) equipped with a Cu tube, with a 
spatial resolution of 5.5 µm and a rotation step of 0.40° (N = 1).  The X-ray source was 
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operated using a tube voltage of 60kV and current of 100 µA. 
 
2.7 Stability Study 
In the first part of the study, ASA tablets containing unground MCC or 20, 40, or 60 
minutes ground MCC were stored in an airtight container under approximately 96% 
relative humidity provided by a saturated solution of potassium sulfate.  The container 
was stored at room temperature, approximately 25˚C, for two weeks.  After storage, 
liquid chromatography assays were carried out for each tablet (N = 1) to measure the 
hydrolysate product of ASA, i.e., salicylic acid. 
In the second part of the study, ASA tablets containing unground MCC or 90 minutes 
ground MCC were stored in an airtight container under approximately 75% relative 
humidity provided by a saturated solution of sodium chloride.  The container was 
stored in an incubator kept at 40˚C for four weeks.  Tablets were sampled every seven 
days and assayed for amounts of salicylic acid using liquid chromatography (N = 3). 
The assay of salicylic acid by liquid chromatography was performed as follows: Each 
tablet was suspended in a mixture of water and methanol (1:3), and the concentration of 
the ASA was about 1 mg/mL.  The suspension was filtered and assayed by liquid 
chromatography.  An octadecylsilyl column, XBridge C18 (2.5 μm in particle size, 4.6 
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mm in diameter × 5 cm in length, Waters) was used.  The mobile phase was a mixture 
of 0.1% phosphoric acid aqueous solution and acetonitrile (1:4).  The detector was an 
ultraviolet absorption photometer (wavelength: 254 nm).  An amount of salicylic acid 
was calculated using the following formula: Amount (%) of salicylic acid = [Peak area 
of salicylic acid] / ([Peak area of ASA] + [Peak area of salicylic acid]) × 100. 
 
 
3. Results and Discussion 
3.1 Crystallinity of Ground Microcrystalline Cellulose 
The change in MCC crystallinity induced by grinding was investigated by XRD.  
The XRD patterns of the MCC powder samples are shown in Figure 3-2(a).  The 
crystalline structure of cellulose provides distinct peaks at 15°, 16.4° and 22.5°.  While 
it is not clearly observed in the XRD pattern, it is known that the amorphous component 
also generates a halo peak around 21°.15  In our results the peaks at 15°, 16.4° and 
22.5° gradually decreased and broadened but, in contrast, the halo peak increased with 
grinding time.  The crystallinities of MCC powder calculated from the XRD patterns 
are shown in Figure 3-2(b).  Note that the crystallinity was calculated as the ratio of 
the crystalline and amorphous components using a curve-ﬁtting method.15  It can be 
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seen from Figure 3-2(b) that the crystallinity of MCC gradually decreases with grinding 
time, suggesting the disintegration of the crystalline structure and subsequent 
development of amorphous component. 
 
3.2 Water-penetration into Tablets 
Water penetration into tablets was investigated using water-penetration analysis.  
The penetration times into AAP tablets containing unground MCC or 20, 40, or 60 
minutes ground MCC are shown in Figure 3-3(a).  The densities of tablets used for the 
water-penetration analysis are shown in Figure 3-3(b) for reference.  It should be noted 
that the water-penetration time gradually decreased with the increase in grinding time 
despite no significant variation in density.  We interpreted this to mean that the 
variation of the crystalline structure of MCC predominantly influences the 
water-penetration behavior of the tablets.  The grinding substantially induces variation 
in the polymer structure of MCC.  It eventually decreases the crystallinity of MCC and 
then generates an amorphous structure.16  We believe that the disordered amorphous 
structure tends to bind water via the development of hydrogen bonds between the MCC 
and water molecules, which, in turn, accelerates the penetration of water into the tablets.  
This hypothesis is supported by the smaller variation in penetration time with the 
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chloroform solution which has less polarity and hence less molecular interaction.  
Consequently, it is likely that grinding induces the disintegration of the MCC polymer 
structure and ultimately provides a substantial level of variation in the water-penetration 
property of the tablets. 
 
3.3 Moisture-absorbability of Tablets 
Figure 3-4 represents the variations in tablet weight during the moisture-absorption 
analysis.  When exposed to a controlled atmosphere, each tablet started to absorb water 
molecules to increase its relative weight.  For example, in Figure 3-4, one can find that 
the relative weight obviously increased more rapidly with grinding time, suggesting that 
grinding induces a decrease in crystallinity of MCC which leads to an increase in 
water-absorbability.  It is well known that the water absorption by a tablet is often 
affected by its physical features, for example, tablet porosity.8  One might expect that 
differences in water absorption essentially stem from variation in the tablet porosity 
rather than variation within the polymer structure.  However, our results do not support 
this.  Figure 3-5(a) shows top-view images of the inside of tablets by X-ray CT.  
X-ray CT generates a three-dimensional image of the inside of an object from a large 
series of two-dimensional X-ray images.  The gray level of each pixel in a CT image 
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corresponds to the X-ray attenuation, which is caused by the density and composition of 
the material.17  Thus, the X-ray CT image reflects any differences in tablet density.  
Our X-ray CT results show no significant differences in patterns.  Figure 3-5(b) shows 
the porosities estimated by binarization of three-dimensional images.  Note that the 
porosity, defined as the ratio of pixels having binary value 0 or 1, was calculated after 
the binarization with a threshold set to be one-sixth of the maximum intensity of the 
image.  Our results show no significant differences in porosities.  This lack of 
difference in CT patterns and porosities can be interpreted to mean that the increase in 
the grinding time did not provide any distinguishable difference in the CT images.  In 
fact, the corresponding weights and volumes of the tablets also provided less significant 
differences (data not shown).  These results indicate that the variation of the water 
absorption behaviors shown in Figure 3-4 was induced by the crystallinity of MCC and 
not by the porosity of tablets.  Accordingly, it is likely that the acceleration of 
moisture-absorption occurs by the following mechanism: The grinding process induces 
a decrease in crystallinity of MCC and generates an amorphous component.  As 
discussed above, the disordered amorphous component tends to bind the water molecule 
more strongly via the development of hydrogen bonds between the MCC and water 
molecules, which accelerates the moisture-absorption of tablets.  
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3.4 Stability of Tablets 
So far, we have examined the molecular-level variation of MCC and its influence on 
the absorption property.  It is also useful to know how such a variations in the 
excipient affects the stability of an active pharmaceutical ingredient inside the tablets.  
Figure 3-6(a) shows the variation in salicylic acid content in the ASA tablets stored for 
two weeks.  Under a certain condition, ASA gradually undergoes spontaneous 
hydrolysis.  Such hydrolysis of ASA is compensated for by the development of 
salicylic acid, which can be used as a kind of quantitative index of tablet stability.  For 
example, one can see a noticeable amount of salicylic acid (e.g., 8.68 - 9.31%) was 
detected in the tablets stored for two weeks, reflecting the fact that ASA hydrolyzed 
during this time.  It is also important to note that the amount of salicylic acid gradually 
increased with the increase in grinding time. 
Figure 3-6(b) illustrates the amount of salicylic acid in the tablets plotted against 
storage time.  Tablets prepared using MCC with either 0 or 90 minutes of grinding 
were stored at 40˚C and 75% relative humidity for four weeks.  The change in the 
content of salicylic acid was measured every week.  All tablets showed an obvious 
increase in the salicylic acid content mostly due to high temperature and humidity.  Of 
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note is that the development of salicylic acid was especially pronounced for the tablets 
containing 90 minutes ground MCC.  The results in Figure 3-6(a) and Figure 3-6(b) 
show that the hydrolysis of ASA inside tablets under high humidity conditions was 
accelerated by the grinding time of MCC, i.e. by the decrease in MCC crystallinity. 
It is likely that the decrease in tablet stability occurred due to the following 
mechanism: the water-penetration and moisture-absorbability of tablets containing 
MCC are affected by the crystallinity of MCC.  During storage under high humidity 
conditions, the tablets were exposed to atmospheric moisture.  The moisture absorption 
by tablets was accelerated by the decrease in MCC crystallinity, which led to the 
acceleration of water-penetration into tablets.  ASA inside the tablets containing more 
amorphous MCC made contact with water molecule more often and eventually the 
hydrolysis of ASA was accelerated.  Consequently, these results reveal that 
molecular-level alternation of the excipient can provide possible variations in the 
pharmaceutical properties of the tablets.  We have shown that the variation of 
crystalline structure of MCC has crucial effects on not only the water-penetration and 
moisture-absorbability but also stability which is one of the most important properties 
of pharmaceutical tablets. 
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4. Conclusion 
In this study, we investigated the effects of MCC crystallinity on the 
water-penetration, moisture-absorbability and stability of tablets by using tablets 
containing 20% MCC.  The stronger interaction between MCC and water molecules 
induced by the decrease in the crystallinity of MCC increased the water-penetration and 
moisture-absorbability.  In addition, the increases in the water-penetration and 
moisture-absorbability eventually changed the stability of an active pharmaceutical 
ingredient inside tablets, that is to say, accelerated the hydrolysis of ASA during storage 
under high humidity conditions.  Though crystal structures of active pharmaceutical 
ingredients are strictly controlled during the manufacturing processes of pharmaceutical 
products, those of excipients are often overlooked.  However, the results in this study 
indicate that the crystallinity of MCC has crucial effects on the product performance 
even when the tablets contain only 20% MCC.  Therefore, the control of crystal 
structure of excipients during the manufacturing process is also important for the 
control of product qualities. 
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Figure 3-1 Chemical structures of (a) cellulose, (b) acetaminophen (AAP), (c) aspirin 
(ASA), and (d) anhydrous dibasic calcium phosphate (DCPA) 
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Figure 3-2 (a) XRD patterns of MCC powder prepared under varying grinding time 
and (b) crystallinity of MCC powder calculated from the XRD patterns 
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Figure 3-3 (a) Penetration time of water (dark gray) and chloroform (light gray) into 
the AAP tablets containing AAP, unground or ground MCC, DCPA, and 
Mg-St and (b)densities of these tablets 
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Figure 3-4 Moisture-absorption by the tablets containing MCC ground for 
0(continuous line), 20 (dotted line), 40 (dashed line), and 60 minutes 
(dashed-dotted line) 
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Figure 3-5 (a) X-ray CT images of the tablets containing MCC prepared under 
varying grinding time and (b) the porosities of tablets estimated by 
three-dimensional image of X-ray CT 
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Figure 3-6 (a) Amounts of salicylic acid in the ASA tablets containing ASA, unground 
or ground MCC, DCPA, and Mg-Stafter two weeks’ storage at room 
temperature/96%RH and (b) amounts of salicylic acid during four weeks’ 
storage at 40˚C/75%RH 
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Chapter 4 
 
Monitoring of Recrystallization of 
Microcrystalline Cellulose inside 
Pharmaceutical Tablets during Storage using 
Near-infrared Diffuse Reflectance Spectroscopy 
 
107/139 
 
Abstract 
Changes in the crystallinity of microcrystalline cellulose (MCC) inside 
pharmaceutical tablets during storage was monitored by near-infrared (NIR) diffuse 
reflectance spectroscopy to probe transient variation at the molecular level.  The MCC 
used in the tablets was ground before tablet formulation to intentionally cause a 
decrease in crystallinity.  The variation in crystalline structure of MCC was evaluated 
from the intensity of NIR spectra peaks ascribed to OH groups in the crystalline region.  
The MCC exhibited obvious signs of recrystallization during 63 days of storage.  In 
addition, the recrystallization became even more pronounced when the MCC was stored 
under high humidity conditions.  Results also showed that the inclusion of anhydrous 
silicic acid induces obvious delay in recrystallization by restricting the penetration of 
water molecules into the tablets.  The findings derived from NIR spectra were 
substantiated by differential thermal analysis.  The results from this study suggest that 
crystallinity of MCC inside tablets can be controlled by other excipients during storage, 
which has useful applications for controlling pharmaceutical product performance 
during storage. 
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1. Introduction 
Controlling the crystal structures of formulation components is important for quality 
control of pharmaceutical products.  It is known that polymorphism of active 
pharmaceutical ingredients, for example, affects their dissolution, 
moisture-absorbability, and stability.1-3  Polymorphism also affects pharmaceutical 
product performance such as dissolution, moisture-absorbability, and stability, which 
eventually causes substantial changes in the quality and bioavailability of the products.  
Therefore, crystal structures of active pharmaceutical ingredients should be strictly 
controlled during the manufacturing processes of pharmaceutical products as well as 
during storage.  On the other hand, the crystal structures of excipients are often 
overlooked in formulation design, and their crystal transformation behavior during 
storage has hardly been investigated, even though the crystal structures of excipients 
can affect pharmaceutical product performance.4-6 
Microcrystalline cellulose (MCC) is a well-known excipient commonly included in 
pharmaceutical tablets as a diluent, binder, and disintegrator.  We previously reported 
that some manufacturing steps such as grinding or compression can induce the 
disintegration of crystalline structure of MCC which in turn induces changes in 
moisture-absorbability, water-penetration, and stability of tablets.7-9  The variation in 
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the crystallinity of MCC also affects the hardness and dissolution profile of tablets.6  
The disordered amorphous structure of MCC can bind water molecules more strongly 
than the crystalline structure and Variation in the affinity to water molecules can induce 
changes in the performance of the tablets.10, 11  Thus, knowledge about crystallinity 
changes in MCC will be useful for the control of quality of tablets containing this 
excipient. 
In general, active pharmaceutical ingredients as well as excipients in tablets 
essentially undergo molecular-level variations depending on storage conditions.  It is 
thus important to develop an in-depth understanding of the molecular-level alterations 
of MCC during storage to control the pharmaceutical performance of tables.  
Near-infrared (NIR) spectroscopy is a non-destructive and non-invasive technique, 
which is widely used in quality control of pharmaceutical products, especially in the 
monitoring of manufacturing processes as represented by Process Analytical 
Technology (PAT).12-15  NIR spectroscopy also provides an interesting opportunity to 
elucidate the physical and chemical information inside pharmaceutical products, i.e. 
tablets, due to the significant light penetration property of NIR light.16-19  Another 
notable feature of NIR spectroscopy is that the NIR spectrum is more sensitive to 
changes in hydrogen bonding, compared to infrared spectroscopy and Raman 
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spectroscopy, making it possible to elucidate subtle but important molecular-level 
variations in the sample.16-19  Consequently, NIR spectroscopy is a powerful tool for 
the evaluation of the polymeric structure of MCC inside tablets.  In fact, we have 
evaluated the crystallinity of MCC inside tablets using NIR spectroscopy in previous 
studies.20, 21 
In this study we explored changes in the crystallinity of MCC inside tablets during 63 
days of storage using NIR diffuse reflectance spectroscopy.  Tablets with different 
formulations ranging 100 – 50% MCC and 0 – 50% anhydrous silicic acid were 
prepared using ground MCC which has low crystallinity.  Sets of time-dependent NIR 
spectra of the tablets revealed that MCC recrystallized during storage.  Importantly, we 
found that such recrystallization of MCC was more pronounced when the samples were 
stored under higher humidity conditions, indicating that recrystallization occurs due to 
the development of hydrogen bonding between the MCC polymer chains via the 
absorbed water molecules.  The results also revealed that the inclusion of an excipient, 
in this case anhydrous silicic acid, induced an obvious delay in recrystallization, by 
restricting the penetration of the water molecules into the tablet.  Such in-depth 
insights into MCC behavior derived from the time-dependent NIR spectra of the tablets 
may have useful applications in controlling the polymer structure of MCC during 
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storage, which, in turn, can be used to control the quality of pharmaceutical products.  
 
 
2. Experiment 
2.1 Materials 
MCC, CEOLUS® (PH-101), was purchased from Asahi Kasei Chemicals Co. (Tokyo, 
Japan).  Anhydrous silicic acid, Aerosil® 200, was purchased from Nippon Aerosil Co., 
Ltd. (Tokyo, Japan).  All reagents used as formulation components were used without 
further purification.  The other reagents were analytical grade. 
 
2.2 Sample Preparation 
The MCC powder was ground for 90 minutes with a vibration sample mill, TI-100 
(Cosmic Mechanical Technology Co., Ltd., Fukushima, Japan) fitted with a porcelain 
rod, before being mixed with anhydrous silicic acid.  The composition of the MCC and 
anhydrous silicic acid in the samples are shown in Table 4-1.  Then 100 mg of the 
mixed powder was compressed to make a set of tablets with a manual tableting machine, 
HANDTAB-100 (Ichihashi-Seiki Co., Ltd., Kyoto, Japan), at a fixed pressure level.  
The powder was placed inside the 8 mm diameter die.  The 10 kN pressure was 
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gradually applied to the upper punch to avoid the generation of unwanted frictional heat.  
The pressure was released immediately after reaching 10 kN.  The samples were 
handled at approximately 25˚C and 75% relative humidity. 
 
2.3 X-ray Powder Diffraction Analysis 
X-ray powder diffraction (XRD) profiles of MCC powder were recorded with an 
X-ray diffractometer, RINT-ULTIMA III (Rigaku Co., Tokyo, Japan).  The diffracted 
intensity under Cu Ka radiation (40 kV and 50 mA) was measured with scan range of 
5 – 40° and scan step of 0.02° at scan rate of 2°/min. 
 
2.4 Stability Study 
One set of the tablets shown in Table 4-1 (Tab0 to Tab5) was stored in an airtight 
container kept under dry conditions using silica gel and one set of tablets was stored in 
an airtight container kept at a relative humidity of 85% using a saturated solution of 
potassium chloride.  These containers were stored at room temperature, 
approximately 27˚C, for 63days. 
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2.5 Near-infrared Diffuse Reflectance Spectroscopy 
Each set of tablets stored under either dry or high humidity conditions were sampled 
2, 5, 8, 12, 15, 19, 22 and 63 days later and their NIR diffuse reflectance spectra were 
collected by an FT-NIR spectrometer, MPA (Bruker Optics K.K., Tokyo, Japan).  
Tablets stored under dry conditions were used as they were, without any additional 
drying before spectral measurements were taken.  Tablets stored under high humidity 
conditions were first placed in an airtight container with silica gel for four hours 
before spectral measurements were taken.  Each spectrum was collected over the 
7600 – 6000 cm-1 region with 8 cm-1 resolution by co-adding 256 scans.  Five spectra 
were collected per tablet.  A background spectrum was measured with a gold film 
supplied with the MPA. 
 
2.6 Thermal Analysis 
Differential thermal analysis of the tablets stored under dry or high humidity 
conditions for 63 days was performed with a thermal gravimetric-differential thermal 
analyzer, TG/DTA6200 (Hitachi High-Tech Science Co., Tokyo, Japan) (N = 3).  
Each tablet was milled with an agate mortar before being analyzed.  Variation in heat 
flow was measured over the temperature range 100 to 450˚C increased at a rate of 
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10˚C a minute.  Melting calories of the MCC were calculated from the differential 
thermal analysis curves. 
 
 
3. Results and Discussion 
3.1 Crystallinity of Ground Microcrystalline Cellulose 
The change of MCC crystallinity induced by the grinding process was investigated by 
XRD.  The XRD patterns of the MCC powder samples are shown in Figure 4-1.  The 
crystalline structure of cellulose provides distinct peaks at 15°, 16.4° and 22.5°.  While 
it is not clearly observed in the XRD pattern, it is known that the amorphous component 
also generates a halo peak at around 21°.22  The peaks of the ground MCC at 15°, 
16.4° and 22.5° flattened out and, by contrast, the halo peak increased with grinding.  
In fact, the crystallinities of MCC and ground MCC calculated from the XRD patterns 
were 80.5% and 70.1%, respectively.  Note that the crystallinity was calculated as the 
ratio of the crystalline and amorphous components by using a curve-ﬁtting method.22  
It is therefore likely that grinding substantially induces disintegration of the MCC 
crystalline structure and leads to subsequent development of the disordered amorphous 
form. 
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3.2 Effects of Humidity on Recrystallization of MCC 
Figure 4-2(a) shows the NIR spectra of TAB0 measured before storage and after 63 
days’ storage under dry conditions.  The peak at 6995 cm-1 is assignable to the first 
overtone of the OH stretching mode of OH groups in the amorphous region of MCC 
with weak hydrogen bonds.23  The peak at 6295 cm-1 is ascribed to hydrogen-bonded 
OH groups in the crystalline region of MCC.23-25  It is important to point out here that 
spectral intensity in this NIR region all decreased during storage.  Such variation in 
intensity is probably due to the change in the polymer structure of the MCC as well as 
the baseline fluctuation arising from light scattering.  For example, the downward shift 
of the baseline was removed by the second derivative and it was then possible to 
identify chemically meaningful variations in some peak intensities without being 
hampered by the unwanted fluctuation of the baseline and overlapping of several peaks.  
Figure 4-2(b) and (c) show the second derivative spectra over the wavenumber 7150 - 
6800 cm-1 and 6400 - 6150 cm-1, respectively.  In Figure 4-2(b), we can see that the 
intensity of the amorphous peak at 6995cm-1 showed a slight increase during storage.  
This increase in intensity can be mostly interpreted as the quantitative decrease in the 
amorphous content of the MCC.  The intensity of the crystalline peak at 6295cm-1 in 
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Figure 4-2(c), on the other hand, decreased during storage, suggesting the additional 
development of the cellulosic crystalline structure.  Figure 4-3(a) shows the NIR 
spectra of TAB0 measured before storage and after 63 days’ storage under high 
humidity conditions, and Figure 4-3(b) and (c) show the corresponding second 
derivative spectra over the wavenumber 7150 - 6800 cm-1 and 6400 - 6150 cm-1, 
respectively.  The trend in the variation of the spectral intensity results was very 
similar to that shown in Figure 4-2, revealing that the samples also underwent 
substantial variation of the supermolecular structure of the MCC.  Consequently, it is 
very likely that the amorphous structures of the MCC samples recrystallized during 
storage which would account for the obvious variations in the spectral feature as shown 
in Figure 4-2 and 4-3. 
So far the results have identified obvious variations in the crystalline and amorphous 
structures of MCC under certain conditions.  Importantly, such spontaneous variations 
seem to be essentially influenced by the storage conditions.  This view is strengthened 
by the results shown in Figure 4-4, which illustrates the change in the spectral 
intensities of the crystalline peaks over storage time.  Note that Figure 4-4 was derived 
from the second derivative spectra.  The intensity of the second derivative spectra were 
scaled to the range [-1 0].  In Figure 4-4, the intensity of the crystalline peak at 
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6295cm-1 gradually decreases with storage time, indicating an increase in crystalline 
content, induced by recrystallization.  We also noted that the changes in samples stored 
under high humidity conditions predominantly occurred earlier than the changes that 
occurred in samples kept under dry conditions.  This indicates that the recrystallization 
of the MCC becomes more pronounced when stored under high humidity conditions.  
That is to say, the presence of more water molecules can accelerate the recrystallization 
of MCC. 
In fact, this hypothesis is clearly supported by the melting calories of the MCC inside 
the samples.  As shown in Figure 4-5, the melting calories of TAB0 stored under high 
humidity conditions were more than those of TAB0 stored under dry conditions, which 
shows that the crystallinity of the MCC increased when stored under high humidity 
conditions.  These results indicate the recrystallization mechanism as follows: 
atmospheric moisture was predominantly absorbed into the amorphous region and the 
MCC recrystallized by forming hydrogen-bonds between the MCC chains via the water 
molecules. 
 
3.3 Effects of an Excipient on Recrystallization of MCC 
It is also of practical interest to know the effect of excipient content, i.e. anhydrous 
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silicic acid, on the recrystallization behavior during high humidity storage.  Figure 4-6 
shows the normalized peak intensities of the crystalline peaks of TAB0 (0% anhydrous 
silicic acid content) and TAB5 (50% anhydrous silicic acid content) plotted against 
storage time.  Note that the spectra were already subjected to second derivative to 
remove unwanted baseline fluctuation and partially resolve overlapping of the peaks in 
the NIR region.  We can see that the changes in the intensity of the crystalline peak of 
TAB0 predominantly occurred earlier than the changes in TAB5.  It should be noted 
that the changes in spectral intensities of the other tablets containing anhydrous silicic 
acid, TAB1, TAB2, TAB3, and TAB4, were also slower than TAB0 (data not shown).  
These results indicate that the anhydrous silicic acid restricts the penetration of water 
molecules into the tablet, which provides an obvious delay in the recrystallization, even 
under high humidity conditions.  Melting calories of MCC inside these six different 
tablet formulations stored under dry or high humidity conditions for 63 days were 
measured by thermal analysis.  Figure 4-7 shows the ratio between the melting calories 
of tablets stored under the two different conditions.  The ratio of the melting calories of 
TAB0, the tablet containing ground MCC only, at 1.73, was the largest among the six 
formulations.  That is to say, the recrystallization of the MCC in the high humidity 
storage was the most pronounced among the samples.  By contrast, the values of the 
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ratios of the other tablets containing anhydrous silicic acid were much smaller than the 
ratio of TAB0 and varied between 0.92 and 1.16.  This shows that recrystallization of 
the MCC inside these tablets can be restricted even during the storage under high 
humidity conditions.  These results support the results derived from the NIR spectra.  
It is conceivable that the anhydrous silicic acid interacts with the amorphous region of 
the MCC or water molecules to inhibit the development of hydrogen-bonds between 
MCC chains, which then restricts the recrystallization of MCC, even under high 
humidity conditions. 
 
 
4. Conclusion 
In this study, we monitored the transient variations in the crystallinity of MCC inside 
tablets during storage using NIR spectroscopy.  Ground MCC powder which has a low 
crystallinity was used for formulation of the tablets to explore the possible 
crystallization behavior of the MCC during storage.  Substantial levels of variation in 
NIR spectral features were readily detected during storage.  Fine details of the change 
in the crystallinity were evaluated intensity of the peak at 6295 cm-1 ascribed to OH 
groups in the crystalline region of MCC.  Obvious increases in the crystalline content 
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were observed during the storage.  Additionally, the MCC recrystallized more 
prominently under high humidity conditions than under dry conditions, suggesting 
additional development of intermolecular interaction between the MCC chains via the 
water molecules.  Interestingly, it was also revealed that such recrystallization is 
readily restricted by the incorporation of anhydrous silicic acid even during high 
humidity storage.  These results indicate that the recrystallization mechanism is as 
follows: Atmospheric moisture is absorbed on the amorphous region of MCC and 
induces formation of hydrogen-bonds between MCC chains.  By contrast, anhydrous 
silicic acid interacts with the amorphous region of the MCC or water molecule and 
inhibits the formation of hydrogen-bonds between the MCC chains.  The crystallinity 
of MCC can affect some pharmaceutical properties of tablets.6-9  Therefore, the control 
of crystallinity of MCC inside pharmaceutical products during storage has important 
implications for quality control of products containing MCC.  It is likely that 
crystallinity of MCC inside tablets can be controlled by other excipients during storage, 
which has useful applications for controlling pharmaceutical product performance 
during storage. 
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Table 4-1 Formulation composition of tablets containing MCC and anhydrous silicic 
acid 
 
 
Ground MCC 
(wt%) 
Anhydrous silicic acid 
(wt%) 
TAB0 100 0 
TAB1 90 10 
TAB2 80 20 
TAB3 70 30 
TAB4 60 40 
TAB5 50 50 
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Figure 4-1 XRD patterns of MCC (continuous line) and ground MCC (dashed line) 
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Figure 4-2 (a) NIR spectra of TAB0 before storage (dashed line) and after 63 days’ 
storage under dry conditions (continuous line), (b) second derivative 
spectra over the wavenumber 7150 - 6800 cm-1, and (c) second derivative 
spectra over the wavenumber 6400 - 6150 cm-1 
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Figure 4-3 (a) NIR spectra of TAB0 before storage (dashed line) and after 63 days’ 
storage under high humidity condition (continuous line), (b) second 
derivative spectra over the wavenumber 7150 - 6800 cm-1, and (c) second 
derivative spectra over the wavenumber 6400 - 6150 cm-1 
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Figure 4-4 Change in peak intensity of NIR spectra of TAB0 during dry (continuous 
line) and high humidity storage (dashed line) 
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Figure 4-5 Melting calories of TAB0 stored for 63 days under dry conditions (white) 
and high humidity conditions (gray) 
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Figure 4-6 Change in peak intensity of NIR spectra of TAB0 (continuous line) and 
TAB5 (dashed line) during high humidity storage 
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Figure 4-7 Ratio of melting calories of tablets stored under high humidity conditions 
for 63 days divided by melting calories of tablets stored under dry 
conditions 
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Conclusion 
In this thesis, we investigated the mechanism that the manufacturing processes of 
pharmaceutical products change pharmaceutical product performance.  For this 
purpose, we revealed the variation in the physical properties of ingredients at the 
molecular level using NIR spectroscopy. 
 
In Chapter 1, the distribution of the ingredients inside tablets was quantified by NIR 
imaging combined with SMCR analysis.  The results revealed that the homogenous 
distribution of the ingredients inside tablet strongly depended on the grinding time and 
that there was an obvious correlation between distribution of the ingredient and its 
dissolution property from tablets.  In addition, pure spectra obtained by SMCR 
analysis indicated the possibility that the grinding process induced the development of 
intermolecular hydrogen bonding and the crystal structure change of the ingredient.  
These results indicate that the dissolution property of an active pharmaceutical 
ingredient from insoluble waxy matrix tablets can be controlled by its distribution 
which is related to the grinding time.  NIR imaging combined with appropriate 
spectrum analysis can be a powerful and versatile tool to understand how the 
manufacturing processes change the pharmaceutical product performance. 
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In Chapter 2, we revealed that the decrease in the MCC crystallinity induced by 
grinding process increased the moisture-absorbability of the tablets containing MCC.  
The band shift analysis of NIR spectra made it possible to evaluate the MCC 
crystallinity without being hampered by variations in the density or the surface 
roughness of tablets.  Moreover, in Chapter 3, we used more practical tablets 
containing MCC and revealed that the decrease in the MCC crystallinity increased 
moisture-absorbability and water-penetration of tablets.  The variation in 
moisture-absorbability and water-penetration eventually destabilized the 
moisture-sensitive active pharmaceutical ingredients inside tablets.  These results 
indicate that the crystallinity of an excipient has crucial effects on the pharmaceutical 
product performance even when the tablet contains a relatively small amount of the 
excipient.  Therefore, the control of crystal structure of excipients during the 
manufacturing process is important for the quality control of pharmaceutical products. 
In Chapter 4, we monitored the transient variations in the crystallinity of MCC inside 
tablets during storage.  The recrystallization of MCC was more pronounced when the 
tablets containing MCC were stored under high humidity conditions.  The results also 
revealed that the inclusion of other excipient induced obvious delay in recrystallization 
of MCC.  As described in Chapter 2 and Chapter 3, the crystal structure of excipients 
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can have crucial effects on the pharmaceutical product performance.  Therefore, the 
crystal structure of excipients during storage should be controlled.  In addition, it is 
likely that crystallinity of an excipient inside tablets can be controlled by other excipient 
during storage. 
 
In Chapter 1 to Chapter 3, we revealed the mechanisms that the variations in the 
physical properties of ingredients induced by manufacturing processes change the 
pharmaceutical product performance such as dissolution, moisture-absorbability, 
water-penetration, and stability.  The results indicate the possibility that the 
pharmaceutical product performance can be controlled based on the scientific evidence.  
In chapter 4, we indicated the possibility that it may be possible that the variations in the 
pharmaceutical product performance during storage can be controlled by the 
formulation design.  These applications make it possible to design the appropriate 
formulation and to develop the robust manufacturing process based on the scientific 
evidence, which must lead to pursuing the concept of QbD. 
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